Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 147

Showing 26-50 of 147 citing articles:

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues
Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116904-116904
Open Access | Times Cited: 7
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies
Govinda R Hancock, Jason Gertz, Rinath Jeselsohn, et al.
Endocrinology (2024) Vol. 165, Iss. 6
Closed Access | Times Cited: 6
Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment
Mahesh Koirala, Mario DiPaola
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1801-1801
Open Access | Times Cited: 6
A protracted war against cancer drug resistance
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Yuqing Lu, Yuewen Yang, Guanghao Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3360-3382
Open Access | Times Cited: 14
Cetuximab-based PROteolysis targeting chimera for effectual downregulation of NSCLC with varied EGFR mutations
Richa Vartak, Bhavesh Deore, Carlos Sanhueza, et al.
International Journal of Biological Macromolecules (2023) Vol. 252, pp. 126413-126413
Open Access | Times Cited: 13
Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein
Vijay Kumar Bhardwaj, Rituraj Purohit
Applied Materials Today (2024) Vol. 38, pp. 102186-102186
Closed Access | Times Cited: 4
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 4
Discovery of novel benzosultam CRBN ligands
Hoyeong Park, Santosh Shivanand Raikar, Yonghyo Kim, et al.
Bulletin of the Korean Chemical Society (2025)
Closed Access
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy
Laura D'Alessio‐Sands, Joshua Gaynier, Victoria Michel‐Milian, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Staudinger Reaction-Responsive Coacervates for Cytosolic Antibody Delivery and TRIM21-Mediated Protein Degradation
Yishu Bao, Zhiyi Xu, Kai Cheng, et al.
Journal of the American Chemical Society (2025)
Closed Access
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
M. Ambrose, Jin-Hyung Lee, Aleem Syed, et al.
Frontiers in Drug Discovery (2025) Vol. 5
Open Access
Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons
S.M. Ibrahim, Muhammad Umer Khan, Iqra Khurram, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 2
Open Access
Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
Serena Rosignoli, Silvia Giordani, M Pacelli, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 206-206
Open Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
A Comprehensive Overview of Protacs Targeting Hsp90 and Their Client Proteins for Cancer Therapy
Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga
(2025)
Closed Access
Advancements in PROTAC-based therapies for neurodegenerative diseases
Deyuan Kong, Liying Meng, Pengfei Lin, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Design, synthesis, and biological evaluation of novel PROTACs compounds with good ER α degradation ability
Xianfeng Yang, Xi Zheng, Cheng Liu, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 122, pp. 118111-118111
Closed Access
A paradigm shift: analytical ultracentrifugation as a multi-attribute platform method in targeted protein degradation
Alexander E. Yarawsky, J.A. Ronau, Tiffany A. Thibaudeau, et al.
European Biophysics Journal (2025)
Closed Access
Novel hormone therapies for advanced prostate cancer: understanding and countering drug resistance
Zhipeng Wang, Jie Wang, Dengxiong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101232-101232
Open Access
Identification of a novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activity
Naveen Kumar Rampeesa, Rambabu Gundla, Gopal Mudasani, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108316-108316
Closed Access
PROTAC-induced protein structural dynamics in targeted protein degradation
Kingsley Y Wu, Ta I Hung, Chia‐en A. Chang
eLife (2025) Vol. 13
Open Access
Light-Activatable Photochemically Targeting Chimeras (PHOTACs) Enable the Optical Control of Targeted Protein Degradation of HDAC6
Silas Wurnig, Maria Hanl, Thomas Geiger, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Application of Mass Spectrometry for the Advancement of PROTACs
Hao Yin, Baoshuang Zhang, Ruibing Chen
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116829-116829
Closed Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access

Scroll to top